SS Innovations Says it Completed a Human Factors Validation Study for SSi Mantra Surgical Robotic System in September

MT Newswires Live
10/02

SS Innovations International (SSII) said Thursday it completed a human factors validation study for its SSi Mantra surgical robotic system at Johns Hopkins Hospital in September.

The purpose of the study was to provide evidence the SSi Mantra meets the US Food and Drug Administration's requirements for usability and patient safety, the company said.

The company said it expects to submit a 510(k) premarket notification to the FDA for SSi Mantra in Q4.

The company said it could receive FDA clearance to market SSi Mantra in H1 2026, based on standard review timelines.

Price: 6.90, Change: -0.20, Percent Change: -2.82

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10